rs45591233

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001145809.2(MYH14):​c.4753-9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0302 in 1,600,376 control chromosomes in the GnomAD database, including 797 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.023 ( 60 hom., cov: 31)
Exomes 𝑓: 0.031 ( 737 hom. )

Consequence

MYH14
NM_001145809.2 intron

Scores

2
Splicing: ADA: 0.0004698
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -0.0460
Variant links:
Genes affected
MYH14 (HGNC:23212): (myosin heavy chain 14) This gene encodes a member of the myosin superfamily. The protein represents a conventional non-muscle myosin; it should not be confused with the unconventional myosin-14 (MYO14). Myosins are actin-dependent motor proteins with diverse functions including regulation of cytokinesis, cell motility, and cell polarity. Mutations in this gene result in one form of autosomal dominant hearing impairment. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 19-50289427-C-T is Benign according to our data. Variant chr19-50289427-C-T is described in ClinVar as [Benign]. Clinvar id is 44072.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-50289427-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0234 (3565/152286) while in subpopulation NFE AF= 0.0349 (2376/68014). AF 95% confidence interval is 0.0338. There are 60 homozygotes in gnomad4. There are 1709 alleles in male gnomad4 subpopulation. Median coverage is 31. This position pass quality control queck.
BS2
High AC in GnomAd4 at 3565 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MYH14NM_001145809.2 linkuse as main transcriptc.4753-9C>T intron_variant ENST00000642316.2 NP_001139281.1 Q7Z406-2A1L2Z2B3KWH4
MYH14NM_001077186.2 linkuse as main transcriptc.4654-9C>T intron_variant NP_001070654.1 Q7Z406-6B3KWH4
MYH14NM_024729.4 linkuse as main transcriptc.4630-9C>T intron_variant NP_079005.3 Q7Z406-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MYH14ENST00000642316.2 linkuse as main transcriptc.4753-9C>T intron_variant NM_001145809.2 ENSP00000493594.1 Q7Z406-2

Frequencies

GnomAD3 genomes
AF:
0.0234
AC:
3565
AN:
152168
Hom.:
60
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00654
Gnomad AMI
AF:
0.00987
Gnomad AMR
AF:
0.0318
Gnomad ASJ
AF:
0.0251
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00600
Gnomad FIN
AF:
0.0226
Gnomad MID
AF:
0.0190
Gnomad NFE
AF:
0.0349
Gnomad OTH
AF:
0.0296
GnomAD3 exomes
AF:
0.0234
AC:
5345
AN:
228342
Hom.:
83
AF XY:
0.0237
AC XY:
2925
AN XY:
123624
show subpopulations
Gnomad AFR exome
AF:
0.00604
Gnomad AMR exome
AF:
0.0223
Gnomad ASJ exome
AF:
0.0277
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00522
Gnomad FIN exome
AF:
0.0230
Gnomad NFE exome
AF:
0.0342
Gnomad OTH exome
AF:
0.0277
GnomAD4 exome
AF:
0.0309
AC:
44690
AN:
1448090
Hom.:
737
Cov.:
32
AF XY:
0.0302
AC XY:
21705
AN XY:
718932
show subpopulations
Gnomad4 AFR exome
AF:
0.00510
Gnomad4 AMR exome
AF:
0.0224
Gnomad4 ASJ exome
AF:
0.0255
Gnomad4 EAS exome
AF:
0.000102
Gnomad4 SAS exome
AF:
0.00575
Gnomad4 FIN exome
AF:
0.0258
Gnomad4 NFE exome
AF:
0.0355
Gnomad4 OTH exome
AF:
0.0284
GnomAD4 genome
AF:
0.0234
AC:
3565
AN:
152286
Hom.:
60
Cov.:
31
AF XY:
0.0230
AC XY:
1709
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.00652
Gnomad4 AMR
AF:
0.0318
Gnomad4 ASJ
AF:
0.0251
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00580
Gnomad4 FIN
AF:
0.0226
Gnomad4 NFE
AF:
0.0349
Gnomad4 OTH
AF:
0.0293
Alfa
AF:
0.0267
Hom.:
30
Bravo
AF:
0.0235
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxOct 13, 2017This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 07, 20124753-9C>T in Intron 34 of MYH14: This variant is not expected to have clinical s ignificance because it has been identified in 3.5% (244/6890) of European Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs45591233). -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsDec 07, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -
Autosomal dominant nonsyndromic hearing loss 4A Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.55
CADD
Benign
14
DANN
Benign
0.85

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00047
dbscSNV1_RF
Benign
0.25
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs45591233; hg19: chr19-50792684; API